Free Trial

Congress Asset Management Co. Has $65.27 Million Stock Holdings in Integer Holdings Corporation $ITGR

Integer logo with Medical background

Key Points

  • Congress Asset Management Co. increased its stake in Integer Holdings Corporation by 1.6% to hold 530,807 shares, valued at $65.27 million.
  • Analyst ratings for Integer indicate strong confidence, with one analyst giving a "Strong Buy" rating, seven "Buy" ratings, and an average price target of $140.25.
  • Integer reported a revenue increase of 11.4% year-over-year, with earnings per share of $1.55 for the last quarter, slightly missing expectations.
  • Five stocks we like better than Integer.

Congress Asset Management Co. lifted its position in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 1.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 530,807 shares of the medical equipment provider's stock after purchasing an additional 8,151 shares during the quarter. Congress Asset Management Co. owned 1.52% of Integer worth $65,273,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of ITGR. Opal Wealth Advisors LLC acquired a new position in shares of Integer in the 1st quarter valued at $28,000. AdvisorNet Financial Inc acquired a new position in Integer in the first quarter worth about $28,000. Bessemer Group Inc. raised its position in Integer by 73.1% in the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 125 shares in the last quarter. SVB Wealth LLC acquired a new position in Integer in the first quarter worth about $35,000. Finally, GAMMA Investing LLC raised its position in Integer by 20.2% in the second quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider's stock worth $98,000 after purchasing an additional 134 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ITGR has been the subject of a number of recent research reports. Raymond James Financial dropped their target price on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a report on Friday, July 25th. Wall Street Zen raised Integer from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Truist Financial cut their price objective on Integer from $145.00 to $137.00 and set a "buy" rating for the company in a report on Friday, July 25th. Finally, Wells Fargo & Company cut their price objective on Integer from $152.00 to $132.00 and set an "overweight" rating for the company in a report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Integer currently has an average rating of "Buy" and a consensus price target of $140.25.

Get Our Latest Stock Report on Integer

Integer Stock Performance

ITGR stock opened at $101.86 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.41 and a quick ratio of 2.18. The company has a 50 day moving average price of $106.70 and a 200 day moving average price of $114.76. Integer Holdings Corporation has a fifty-two week low of $99.73 and a fifty-two week high of $146.36. The stock has a market capitalization of $3.57 billion, a PE ratio of 44.87, a price-to-earnings-growth ratio of 0.81 and a beta of 1.03.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). The firm had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.The company's revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. Analysts forecast that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer Company Profile

(Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Further Reading

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR - Free Report).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Integer Right Now?

Before you consider Integer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.

While Integer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.